Skip to main content

Table 2 Association between MCT1, MCT2, MCT4 and CD147 expressions in prostate tumours

From: Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

 

MCT1

MCT4

MCT2

 

n

Positive (%)

p

n

Positive (%)

p

n

Positive (%)

p

CD147

  

< 0.001

  

< 0.001

  

0.184

Negative

59

20.3

 

84

26.7

 

35

40.0

 

Positive

107

64.5

 

83

63.0

 

131

50.4

 
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us